Stress May Increase Levels of Alzheimer's Protein
the Psychiatry Advisor take:
A hormone released by the brain in response to stress boosts production of a protein associated with the development of Alzheimer’s disease.
Todd Golde, PhD, of the Center for Translational Research in Neurodegenerative Disease at the University of Florida, and colleagues analyzed the brains of mice who were subjected to acute stress, and compared them with mice who were not stressed.
The stressed mice had more toxic beta-amyloid protein in their brains than the non-stressed mice, the researchers reported in The EMBO Journal. Beta-amyloid is known to clump together into plaques, interrupting brain cell communication.
They also found that stress leads to corticotrophin releasing factor (CRF), a hormone, to be released in the brain. This, in turn, boosts the activity of gamma secretase, an enzyme, which increases production of beta-amyloid.
“These data collectively link CRF to increased beta-amyloid through gamma secretase and provide mechanistic insight into how stress may increase [Alzheimer’s disease] risk,” say the authors.
The findings may point to a new treatment strategy of targeting CRF with an antibody to decrease the amount of stress hormone and, in turn, reduce beta-amyloid production. However, the researchers admit this approach will be challenging.
Stressed mice had more toxic beta-amyloid protein in their brains than the non-stressed mice.
Previous research has linked stress with increased risk of Alzheimer's disease, but the mechanisms underlying this association have been unclear. Now, researchers from the University of Florida believe they are one step closer to an explanation.
Researchers say stress triggers the release of a hormone that boosts production of a protein in the brain that is involved in the development of Alzheimer's.
In a study published in The EMBO Journal, Dr. Todd Golde, director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida, and colleagues describe how a hormone released by the brain in response to stress increases production of a protein associated with Alzheimer's development.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- FDA Approves Schizophrenia Medication With Digital Ingestion Sensor
- Increased Depression Severity Following Childhood Exposure to Adversity, Risk
- Suboptimal Neuromotor Development Related to Genetic Risk for Schizophrenia
- No Association Between Comorbid Anxiety Disorders, Suicide Attempts
- Cannabidiol Concentration, Labeling Varies Widely in Products Sold Online
- Maintenance rTMS for Treatment-Resistant Depression
- Eye Movement Desensitization and Reprocessing Reduces PTSD Symptoms
- Micronutrients Improve Some Symptoms of ADHD
- Long-Acting Injectable Antipsychotics Delay Schizophrenia Relapse
- Transcranial Stimulation Reduces Auditory Hallucinations in Schizophrenia
- Borderline Personality Disorder: Not Just an Adult Condition
- Prior Mental Disorders Linked to Subsequent Onset of Chronic Back or Neck Pain
- Posttreatment Brain Effects of Psilocybin in Patients With Treatment-Resistant Depression
- Brexanolone Trials Show Positive Results in Reducing Symptoms of Postpartum Depression
- ADHD Medication Exposure Associated With Increased Neonatal Mortality